Houlihan Financial Resource Group’s Biogen BIIB Stock Holding History

Houlihan Financial Resource Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$73K	Buy	+300	New	+$83.7K	0.04%	146

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Houlihan Financial Resource Group's BIIB Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in Biogen (BIIB) in Q3 2020: 300 shares worth $73K. The stake represents 0.04% of the portfolio and ranks #146 among its holdings.

1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Houlihan Financial Resource Group held 300 shares of Biogen worth $73K as of Q3 2020.
Biogen was a new Houlihan Financial Resource Group position in Q3 2020.
Biogen made up 0.04% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #146 holding.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.